http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105250246-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 |
| filingDate | 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105250246-B |
| titleOfInvention | Application of the protocatechualdehyde in treatment male sterility and extracorporeal treatment sperm |
| abstract | The present invention relates to a kind of protocatechualdehyde to prepare the application in preventing and treating caused by cyclophosphamide male sterility disease drug, belongs to treatment male sterility technical field.Technical scheme is：Protocatechualdehyde is used for male sterility and Reproductive Damage caused by preventing and treating endoxan.Present invention treatment male sterility, relative low price, can be promoted the use of.Protocatechualdehyde, which removes, has anti-oxidative stress, moreover it is possible to improves the protein contents of testis DJ 1, is better than carnitine and vitamin E in treatment male sterility mechanism. |
| priorityDate | 2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 263.